phase 1_initiation
saveShanghai Argo Pharmaceutical Co Ltd — BW-20805 (Phase I Trial Initiation)
community read0 votes
Therapy area: Immunology. Indication: Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Data sources
globaldata
Found something off?
comments(0)
5-min edit window · permanent after that